about
MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac RemodelingMicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic SclerosisGenetics, Epigenetics, and Genomics of Systemic SclerosisTherapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Epigenetics of progression of chronic kidney disease: fact or fantasy?Novel insights into miRNA in lung and heart inflammatory diseasesTGF-β1/Smads and miR-21 in Renal Fibrosis and InflammationSystemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated MiceMiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells.NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agentsRole of the microRNA-29 family in fibrotic skin diseases.Pathogenesis of arrhythmias in a model of CKD.The role of microRNAs in the pathogenesis of MMPi-induced skin fibrodysplasia.Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosisA microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.Pathophysiological role of microRNA-29 in pancreatic cancer stromaHigh-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells1α,25-Dihydroxyvitamin D3 prevents the differentiation of human lung fibroblasts via microRNA-27b targeting the vitamin D receptor.Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease.Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.Primary Angle Closure and Sequence Variants within MicroRNA Binding Sites of Genes Involved in Eye DevelopmentAutophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism.Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.MicroRNA and nephropathy: emerging concepts.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.The role of microRNAs in skin fibrosis.Influence of age on wound healing and fibrosis.Regulatory RNAs and paracrine networks in the heart.Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.The emerging role of miRNAs in inflammatory bowel disease: a review.Circulating Extracellular microRNA in Systemic Autoimmunity.Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead.Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells.miR-19a, -19b, and -26b Mediate CTGF Expression and Pulmonary Fibroblast Differentiation.Exosomes in immunoregulation of chronic lung diseases.Epigenetic factors as drivers of fibrosis in systemic sclerosis.Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy.
P2860
Q26740102-FE5AC43F-9B6B-474C-9CA7-312A3FBBD02BQ26781257-A0324418-D199-43DE-A754-EC9BEFC094ADQ26799577-82B723C3-758A-40BA-AE83-41DD45B92E93Q26829662-CBCD9934-9506-4EF6-9716-CAC3BB8698F0Q27005788-73ADFBD4-5643-4AAD-B261-5A101912E859Q27026348-3CED2315-7755-4CD6-9972-2F71AAE866A5Q28067425-5BE6D664-9E5C-4CE7-9847-8D5E7B6E9B46Q28546811-2E8FE3F7-8B96-43A8-B07B-7566D1BD0D55Q30300319-B83856CA-3540-49B6-970F-98E92FF28011Q33705075-1B5E2895-261C-43C8-B95E-A2322B718C1DQ33742115-05C3E1D9-BB10-4308-A3E4-9CBC30E4E79CQ34568828-BED1766D-FAE0-4487-950C-D44762F88FAAQ34728974-8AFFAA0F-626E-49D1-9A0C-4ABF3F9A41C7Q34994708-AB4A5AE7-4B07-41C6-8BC9-E2DA4CA40562Q35605375-4F7DBF25-8AA9-4414-A9E8-A67D042A3ED6Q35765000-D4AB106A-89E7-4444-8D21-3775BFB95794Q35842588-8EC1C7C6-FD80-4876-BD8A-E41BF68E7C74Q36041636-89FADC0A-0417-4B41-9187-1467DE2B9A42Q36063043-883C0547-B592-43F3-96B8-4771139AC40AQ36069681-935C5BAF-0C8A-46FD-BBAC-A436C237959BQ36088154-09985D6A-6592-43F1-8287-6B913505DE28Q36089694-AE1CBCBE-54FD-432B-AE3C-D4B5B6717F87Q36185723-6FAE7D52-8A8F-457C-8450-5C45C22AF5D4Q36819566-AF327BCB-787F-4B9D-A41E-91C8519C5043Q36961089-BD3BBA40-5290-455B-AEFC-E4418BD99D4EQ37165647-0AB0E82E-0A3D-41C4-8BA6-00E8B7957AB3Q37221074-ED654375-96F7-4425-B088-0C78691D302EQ37224668-8953BEA2-5307-4728-9363-5B381B0A21EEQ37691772-D98219EB-6775-4A78-AD06-9E3EACE87606Q38057707-FBA986D5-3967-4A6B-A251-C1B39565E1B9Q38190443-CE67F33D-9CF0-4F98-AC14-D18C719AA26FQ38205150-613F4406-DF9F-4E2A-BBF2-34B004DA20BFQ38305049-112703AC-EE1E-4F62-BB5F-11A25480872CQ38648011-0F972001-7409-438B-BD4A-957E5EE198AFQ38703251-1DDDDBBD-E374-44BC-AF5E-7140D9A1D884Q38772085-B4ED9773-CFBC-49EA-972D-64438C9F3915Q38794416-2405E0B9-935C-43E9-90CF-F143E0A3365AQ39012226-8D86AA8A-EDB6-45F6-80DC-C2AB0D3929ACQ39200920-5234EDDC-6CC9-4850-AEA6-39DCE1D146B4Q39434095-81425E09-0588-4F9F-82ED-5222AEA25527
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Role of MicroRNAs in Fibrosis.
@ast
Role of MicroRNAs in Fibrosis.
@en
type
label
Role of MicroRNAs in Fibrosis.
@ast
Role of MicroRNAs in Fibrosis.
@en
prefLabel
Role of MicroRNAs in Fibrosis.
@ast
Role of MicroRNAs in Fibrosis.
@en
P2860
P1476
Role of MicroRNAs in Fibrosis.
@en
P2093
Oliver Distler
Steffen Gay
P2860
P304
P356
10.2174/1874312901206010130
P577
2012-06-15T00:00:00Z